The FDA has approved Saphnelo (anifrolumab-fnia) for subcutaneous administration in patients with systemic lupus ...
The new weekly 120 mg SC formulation, supported by TULIP-SC trial results, offers patients with moderate to severe SLE a self-administered alternative to monthly IV infusions.
The FDA review of the biologics license application includes data on SC isatuximab as both manual injection and via an ...
In Europe, the SC formulation of daratumumab, another anti-CD38 antibody, recently received a label update that allowed ...
Submission supported by data from Phase 3 pivotal AFFIRM study If approved, adult Crohn's disease patients will have an additional option for induction of risankizumab-rzaa ...
AbbVie seeks US FDA approval for Skyrizi subcutaneous induction for adults with moderately to severely active Crohn's disease: North Chicago, Illinois Wednesday, April 29, 2026, 1 ...
The Justice Department will adopt firing squad as a permitted method of execution as the Trump administration moves to ramp ...
Pope Leo reiterated the Catholic Church's teaching that the death penalty is "inadmissible," in a video message released ...
JNJ-4804 demonstrated highest rates of clinical and endoscopic outcomes compared to golimumab and guselkumab in patients with ulcerative colitis or Crohn's disease ...
A Florida man convicted of beating and choking his 13-year-old step-niece to death nearly 50 years ago is set to be executed ...
GLP-1 overdoses are on the rise, and some clinicians suggest informing patients of the risk in the initial consultation.
Biosimilar formulation development requires navigating around scientific, regulatory, and legal challenges, according to Sung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results